摘要
目的观察依达拉奉联合阿司匹林治疗急性脑梗死的临床疗效。方法将该院门诊或住院确诊为急性脑梗死的患者140例作为研究对象,均给予依达拉奉联合阿司匹林治疗,评价治疗4周后患者的治疗总有效率和血液流变学指标。结果治疗总有效率为88.6%。治疗后的血液流变学指标较治疗前均有明显改善,差异有统计学意义(P<0.01)。结论依达拉奉联合阿司匹林治疗急性脑梗死患者,能够明显改善患者的预后,值得在临床上推广。
Objective To observe the effect of edaravone combined with aspirin in the treatment of acute cerebral in- farction. Methods 140 patients who diagnosed with acute cerebral infaretionin in hospital outpatient or inpatient were selected as the research object. All the patients were treated with edaravone and aspirin. After four weeks' treatment, efficiency and blood rheology index were analysed. Results After treatment, the total effective rate was 88.6%, and blood rheology was sig- nificantly improved ,the difference is statistically significant( P 〈 0.01 ). Conclusion Edaravone combined with aspirin in the treatment of patients with acute cerebral infarction can significantly improve the prognosis of patients, and it is worthy of clinical popularization.
出处
《临床合理用药杂志》
2015年第4期9-10,共2页
Chinese Journal of Clinical Rational Drug Use